Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
European Journal of Haematology|January 23, 2019
Sequential liver and haematopoietic stem cell transplantation in a case of fulminant hepatitis associated liver failure and aplastic anaemiaZeyad Al-Shaibani, Sreelakshmi Kotha, Wilson Lam, et al.
American Journal of Hematology|October 1, 2010
Comprehensive evaluation of time-to-response parameter as a predictor of treatment failure following imatinib therapy in chronic phase chronic myeloid leukemia: which parameter at which time-point does matter?Dong Hwan ' Dennis ' Kim, Lakshmi Sriharsha, Chul Won Jung, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|December 15, 2015
Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host diseaseEduardo V Navajas, Hatem Krema, Dena S Hammoudi, et al.
Blood|January 15, 2009
Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemiaDong Hwan Dennis Kim, Wei Xu, Clement Ma, et al.
Blood Cancer Journal|April 23, 2023
Management of chronic myeloid leukemia in 2023 - common ground and common senseJayastu Senapati, Koji Sasaki, Ghayas C Issa, et al.
Blood Reviews|May 15, 2022
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an optionJeffrey H Lipton, Tim H Brümmendorf, Carlo Gambacorti-Passerini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 23, 2020
Late cognitive outcomes among allogeneic stem cell transplant survivors: follow-up data from a 6-year longitudinal studySamantha J Mayo, Isabel Wozniczka, Sarah Brennenstuhl, et al.
Leukemia & Lymphoma|April 25, 2007
Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys) versus interferon alpha-2a (Roferon-A) in patients with treatment-naïve, chronic-phase chronic myelogenous leukemiaJeffrey H Lipton, Nina Khoroshko, Anatoly Golenkov, et al.
British Journal of Haematology|February 13, 2003
Complete remission of tumour with interleukin 2 therapy in a patient with non-Hodgkin's lymphoma post allogeneic bone marrow transplant associated with polyclonal T-cell bone marrow lymphocytosisThomas L Kiss, David Spaner, Andrew S Daly, et al.
Transfusion|July 9, 2013
Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytesFotios V Michelis, Donald R Branch, Iain Scovell, et al.
Pageof 21